Australia's Creso Pharma rises on agreement with Dr Pickles

Melodiol Global Health

23/05/2022 02:13

** Shares of Creso Pharma  CPH.AX  rise as much as 13.5% to
A$0.059, its best session since April 29 if gains hold
    ** The cannabis and hemp maker secures https://www.asx.com.au/asxpdf/20220523/pdf/4596xq3pxff7jy.pdf
 heads of agreement with tattoo aftercare products co Dr Pickles
Pty Ltd
    ** Signs agreement for the introduction of co's target
acquisition co Sierra Sage Herbs' products in the Australian
market
    ** Stock hits highest level since May 4
    ** As of last close, CPH stock down ~36.6% this year 

 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))